Controlled study of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD
This study was terminated in the United States. It focuses on OCD.
In New York
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study was terminated in the United States. It focuses on OCD.
In New YorkThis study is completed in Norway. It focuses on PTSD.
In TrondheimThis study is completed in the United States. It focuses on Eating disorders.
In ChicagoThis study is completed in the United States. It focuses on adults with tardive dyskinesia.
In Chapel HillThis study is completed in the United States. It focuses on OCD.
In Los AngelesThis study is completed. It focuses on PTSD.
Location not clearly listedThis study is completed in the United States, in Kenya, and in Tanzania. It focuses on PTSD.
Multiple locations, including SeattleThis study is completed in the United States. It focuses on Anxiety.
Multiple locations, including ClemsonThis study is completed. It focuses on Addiction.
Location not clearly listedThis study is completed in Pakistan. It focuses on schizophrenia.
Multiple locations, including KarachiThis study is completed in Italy. It is testing ADJUVANT EFFECT OF POLYNSATURED FATTY ACIDS OMEGA-3 for depression.
In ItalyThis study is completed in Italy. It is testing clozapine and aripiprazole versus clozapine and haloperidol for Schizophrenia.
In ItalyHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.